Fingerprint
Dive into the research topics of 'Phase II, open-label, single-arm trial of imatinib mesylate in patients with metastatic melanoma harboring c-Kit mutation or amplification'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically